Yuxin Technology (300674.SZ): A total of 11.373 million shares have been repurchased

Gelonghui, May 5, 丨 Yuxin Technology (300674.SZ) announced that as of April 30, 2024, the total number of shares repurchased by the company through centralized bidding transactions through special stock repurchase accounts was 11.373 million shares, accounting for 1.62% of the company's current total share capital. The highest transaction price was 14.000 yuan/share, the minimum transaction price was 9.970 yuan/share, and the total transaction amount was 139 million yuan (excluding transaction fees).

Gelonghui Finance06:32 ET

Puli Pharmaceuticals (300630.SZ) obtained GMP certification from Saudi Arabian Food and Drug Administration

Puli Pharmaceuticals (300630.SZ) issued an announcement. The company recently received from the Saudi Food and Drug Administration (...

Zhitong Finance04:49 ET

Hengfeng Information (300605.SZ) selected 73.7924 million yuan Zhangzhou Jiulongjiang Hospital intelligent project

Hengfeng Information (300605.SZ) issued an announcement. Recently, the company received a message from Zhangzhou City Investment Construction Engineering Group Co., Ltd....

Zhitong Finance04:41 ET

Century Tianhong (300654.SZ) will pay 0.5 yuan for every 10 shares in 2023. The stock registration date is May 10

According to the Zhitong Finance App, Century Tianhong (300654.SZ) announced that the company will implement the 2023 equity distribution, with a cash payment of 0.5 yuan for every 10 shares. The share registration date is May 10.

Zhitong Finance04:33 ET

Wanfu Biotech (300482.SZ): US subsidiary respiratory triad home self-test OTC products obtained US FDA EUA authorization

Gelonghui May 5 丨 Wanfu Biotech (300482.SZ) issued an announcement that Wanfu Biotech's US wholly-owned subsidiary Wondfo USA Co. , Ltd. (hereinafter referred to as the “US subsidiary”) recently received a notice from U.S. Food & Drug Administration (US Food and Drug Administration, hereinafter referred to as “FDA”) that Wanfu Biotech's US subsidiary's trifecta household test kit for the novel coronavirus, influenza A virus, and influenza B virus (OTC version) WellLife COVID-1

Gelonghui Finance04:27 ET

We Think BGT Group's (SZSE:300774) Healthy Earnings Might Be Conservative

BGT Group Co., Ltd.'s (SZSE:300774) recent earnings report didn't offer any surprises, with the shares unchanged over the last week. Our analysis suggests that shareholders might be missing some posi

Simply Wall St21:57 ET